Update: 13.11.2023
Last week: 44 week 2023 (30.10.2023 - 05.11.2023)
Last full month: October 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 146 350 | -4.4% | 2.9% | 0 | 36 165 516 | -4.0% | 3.0% | 0 | -4.6% |
| MoM | 685 594 | 0.6% | 3.0% | -0.4 | 166 926 496 | 3.0% | 3.1% | -0.5 | 15.1% |
| YTD | 4 380 250 | -48.2% | 2.9% | -2.3 | 1 094 479 932 | -35.2% | 3.3% | -1.8 | -6.4% |
| MAT | 5 778 088 | -47.3% | 3.0% | -2.5 | 1 425 830 152 | -33.6% | 3.3% | -1.9 | -3.1% |
| DEXALGIN | |||||||||
| WoW | 21 293 | -11.4% | 0.4% | 0 | 11 037 585 | -12.7% | 1.1% | -0.2 | -0.5% |
| MoM | 102 990 | 34.4% | 0.4% | 0.1 | 54 000 126 | 38.2% | 1.2% | 0.3 | 5.2% |
| YTD | 813 145 | -43.6% | 0.4% | -0.3 | 420 931 131 | -31.6% | 1.1% | -0.7 | -0.3% |
| MAT | 958 041 | -47.4% | 0.4% | -0.3 | 492 280 065 | -35.4% | 1.1% | -0.8 | 0.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 71 275 | -2.4% | 41.3% | 0.5 | 40 793 601 | -1.9% | 46.1% | 1 | -3.6% |
| MoM | 302 059 | 15.3% | 40.2% | 2 | 171 890 844 | 16.6% | 44.9% | 1.6 | 9.6% |
| YTD | 2 597 225 | -32.3% | 39.5% | -15.7 | 1 541 225 197 | -21.2% | 46.7% | -14 | -5.5% |
| MAT | 3 043 306 | -35.3% | 39.7% | -16.7 | 1 794 917 415 | -24.2% | 47.0% | -15.1 | -8.0% |
| ESPUMISAN BABY | |||||||||
| WoW | 27 338 | -1.4% | 33.5% | -1.1 | 21 688 591 | 0.1% | 48.5% | -0.7 | 1.8% |
| MoM | 121 542 | 20.0% | 35.2% | 2 | 94 117 783 | 27.3% | 49.9% | 3.3 | 13.2% |
| YTD | 996 404 | -19.5% | 32.3% | -5.8 | 744 781 258 | -3.8% | 47.3% | -3.8 | -5.1% |
| MAT | 1 185 387 | -19.8% | 32.4% | -5.9 | 876 401 524 | -4.4% | 47.3% | -4.2 | -5.3% |
| FASTUM | |||||||||
| WoW | 16 384 | -6.8% | 0.8% | 0 | 9 847 857 | -6.7% | 2.0% | -0.1 | -2.7% |
| MoM | 74 252 | 7.7% | 0.8% | 0 | 44 694 797 | 8.0% | 2.1% | -0.1 | 11.6% |
| YTD | 676 551 | -25.8% | 0.9% | -0.3 | 407 944 574 | -13.8% | 2.2% | -0.3 | 2.1% |
| MAT | 805 104 | -27.1% | 0.9% | -0.3 | 481 125 313 | -14.8% | 2.2% | -0.4 | 2.0% |
| IODOMARIN | |||||||||
| WoW | 83 690 | -0.8% | 25.4% | -0.3 | 15 073 775 | -0.8% | 10.0% | -0.3 | 0.6% |
| MoM | 354 624 | 19.8% | 25.0% | 1.8 | 63 733 938 | 20.2% | 9.9% | 0.9 | 11.4% |
| YTD | 3 068 139 | 11.5% | 23.2% | 2.9 | 557 539 905 | 3.3% | 9.4% | 0.3 | -2.6% |
| MAT | 3 611 030 | 8.9% | 23.1% | 2.5 | 657 614 057 | 2.1% | 9.3% | 0 | -2.7% |
| LIOTON | |||||||||
| WoW | 18 629 | 1.3% | 1.9% | 0 | 22 680 641 | 1.8% | 3.9% | 0 | -0.8% |
| MoM | 79 829 | -10.6% | 1.9% | -0.4 | 95 544 768 | -8.1% | 3.8% | -0.7 | 8.7% |
| YTD | 854 040 | -23.9% | 2.1% | -0.5 | 1 051 227 269 | -9.0% | 4.4% | -0.3 | -5.4% |
| MAT | 983 990 | -26.2% | 2.1% | -0.6 | 1 203 861 188 | -10.2% | 4.4% | -0.4 | -5.9% |
| MEZYM | |||||||||
| WoW | 254 830 | 4.2% | 17.2% | -0.2 | 44 587 222 | 5.1% | 12.3% | -0.2 | 5.3% |
| MoM | 1 044 774 | 13.9% | 17.4% | 0.4 | 180 805 122 | 15.6% | 12.7% | 0.4 | 11.5% |
| YTD | 9 584 132 | -38.2% | 18.0% | -8.5 | 1 563 459 151 | -34.0% | 12.6% | -6.4 | -9.0% |
| MAT | 11 431 256 | -40.5% | 18.1% | -9.2 | 1 837 280 520 | -36.5% | 12.7% | -7 | -10.3% |
| MIG 400 | |||||||||
| WoW | 141 436 | -1.3% | 2.5% | 0 | 18 946 926 | -1.5% | 1.9% | 0 | -0.5% |
| MoM | 632 616 | -2.0% | 2.5% | -0.2 | 83 796 209 | 1.7% | 1.9% | -0.1 | 5.2% |
| YTD | 5 463 267 | -25.0% | 2.5% | -0.8 | 698 416 914 | -18.7% | 1.9% | -0.6 | -0.3% |
| MAT | 6 574 984 | -24.6% | 2.5% | -0.8 | 833 875 100 | -18.6% | 1.9% | -0.7 | 0.3% |
| PROSTAMOL | |||||||||
| WoW | 26 035 | 3.4% | 13.3% | 0.3 | 42 411 811 | 3.2% | 15.7% | 0.3 | 0.9% |
| MoM | 113 178 | 16.3% | 13.6% | -0.5 | 187 439 877 | 17.6% | 16.3% | -0.4 | 20.9% |
| YTD | 945 028 | -30.3% | 13.4% | -5.6 | 1 459 851 817 | -23.2% | 15.2% | -5 | -1.3% |
| MAT | 1 134 839 | -32.0% | 13.5% | -6.1 | 1 724 724 994 | -25.3% | 15.1% | -5.6 | -1.3% |
| RESPERO MYRTOL | |||||||||
| WoW | 32 898 | -4.6% | 8.4% | 0 | 17 235 914 | -4.1% | 8.7% | 0.1 | -5.0% |
| MoM | 146 557 | 22.5% | 8.3% | 0.4 | 76 853 359 | 21.4% | 8.6% | 0.1 | 16.9% |
| YTD | 934 764 | -10.7% | 7.4% | -1.1 | 506 631 377 | 2.9% | 8.0% | -0.4 | 2.1% |
| MAT | 1 188 961 | -6.5% | 7.5% | -1 | 637 917 581 | 7.9% | 8.1% | -0.3 | 5.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 4 380 250 | -48.2% | 2.9% | -2.3 | 1 094 479 932 | -35.2% | 3.3% | -1.8 | -6.4% |
| DEXALGIN | 813 145 | -43.6% | 0.4% | -0.3 | 420 931 131 | -31.6% | 1.1% | -0.7 | -0.3% |
| ESPUMISAN (ADULTS) | 2 597 225 | -32.3% | 39.5% | -15.7 | 1 541 225 197 | -21.2% | 46.7% | -14 | -5.5% |
| ESPUMISAN BABY | 996 404 | -19.5% | 32.3% | -5.8 | 744 781 258 | -3.8% | 47.3% | -3.8 | -5.1% |
| FASTUM | 676 551 | -25.8% | 0.9% | -0.3 | 407 944 574 | -13.8% | 2.2% | -0.3 | 2.1% |
| IODOMARIN | 3 068 139 | 11.5% | 23.2% | 2.9 | 557 539 905 | 3.3% | 9.4% | 0.3 | -2.6% |
| LIOTON | 854 040 | -23.9% | 2.1% | -0.5 | 1 051 227 269 | -9.0% | 4.4% | -0.3 | -5.4% |
| MEZYM | 9 584 132 | -38.2% | 18.0% | -8.5 | 1 563 459 151 | -34.0% | 12.6% | -6.4 | -9.0% |
| MIG | 5 463 267 | -25.0% | 2.5% | -0.8 | 698 416 914 | -18.7% | 1.9% | -0.6 | -0.3% |
| PROSTAMOL | 945 028 | -30.3% | 13.4% | -5.6 | 1 459 851 817 | -23.2% | 15.2% | -5 | -1.3% |
| RESPERO MYRTOL | 934 764 | -10.7% | 7.4% | -1.1 | 506 631 377 | 2.9% | 8.0% | -0.4 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 778 088 | -47.3% | 3.0% | -2.5 | 1 425 830 152 | -33.6% | 3.3% | -1.9 | -3.1% |
| DEXALGIN | 958 041 | -47.4% | 0.4% | -0.3 | 492 280 065 | -35.4% | 1.1% | -0.8 | 0.3% |
| ESPUMISAN (ADULTS) | 3 043 306 | -35.3% | 39.7% | -16.7 | 1 794 917 415 | -24.2% | 47.0% | -15.1 | -8.0% |
| ESPUMISAN BABY | 1 185 387 | -19.8% | 32.4% | -5.9 | 876 401 524 | -4.4% | 47.3% | -4.2 | -5.3% |
| FASTUM | 805 104 | -27.1% | 0.9% | -0.3 | 481 125 313 | -14.8% | 2.2% | -0.4 | 2.0% |
| IODOMARIN | 3 611 030 | 8.9% | 23.1% | 2.5 | 657 614 057 | 2.1% | 9.3% | 0 | -2.7% |
| LIOTON | 983 990 | -26.2% | 2.1% | -0.6 | 1 203 861 188 | -10.2% | 4.4% | -0.4 | -5.9% |
| MEZYM | 11 431 256 | -40.5% | 18.1% | -9.2 | 1 837 280 520 | -36.5% | 12.7% | -7 | -10.3% |
| MIG | 6 574 984 | -24.6% | 2.5% | -0.8 | 833 875 100 | -18.6% | 1.9% | -0.7 | 0.3% |
| PROSTAMOL | 1 134 839 | -32.0% | 13.5% | -6.1 | 1 724 724 994 | -25.3% | 15.1% | -5.6 | -1.3% |
| RESPERO MYRTOL | 1 188 961 | -6.5% | 7.5% | -1 | 637 917 581 | 7.9% | 8.1% | -0.3 | 5.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 146 350 | -4.4% | 2.9% | 0 | 36 165 516 | -4.0% | 3.0% | 0 | -4.6% |
| DEXALGIN | 21 293 | -11.4% | 0.4% | 0 | 11 037 585 | -12.7% | 1.1% | -0.2 | -0.5% |
| ESPUMISAN (ADULTS) | 71 275 | -2.4% | 41.3% | 0.5 | 40 793 601 | -1.9% | 46.1% | 1 | -3.6% |
| ESPUMISAN BABY | 27 338 | -1.4% | 33.5% | -1.1 | 21 688 591 | 0.1% | 48.5% | -0.7 | 1.8% |
| FASTUM | 16 384 | -6.8% | 0.8% | 0 | 9 847 857 | -6.7% | 2.0% | -0.1 | -2.7% |
| IODOMARIN | 83 690 | -0.8% | 25.4% | -0.3 | 15 073 775 | -0.8% | 10.0% | -0.3 | 0.6% |
| LIOTON | 18 629 | 1.3% | 1.9% | 0 | 22 680 641 | 1.8% | 3.9% | 0 | -0.8% |
| MEZYM | 254 830 | 4.2% | 17.2% | -0.2 | 44 587 222 | 5.1% | 12.3% | -0.2 | 5.3% |
| MIG | 141 436 | -1.3% | 2.5% | 0 | 18 946 926 | -1.5% | 1.9% | 0 | -0.5% |
| PROSTAMOL | 26 035 | 3.4% | 13.3% | 0.3 | 42 411 811 | 3.2% | 15.7% | 0.3 | 0.9% |
| RESPERO MYRTOL | 32 898 | -4.6% | 8.4% | 0 | 17 235 914 | -4.1% | 8.7% | 0.1 | -5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 685 594 | 0.6% | 3.0% | -0.4 | 166 926 496 | 3.0% | 3.1% | -0.5 | 15.1% |
| DEXALGIN | 102 990 | 34.4% | 0.4% | 0.1 | 54 000 126 | 38.2% | 1.2% | 0.3 | 5.2% |
| ESPUMISAN (ADULTS) | 302 059 | 15.3% | 40.2% | 2 | 171 890 844 | 16.6% | 44.9% | 1.6 | 9.6% |
| ESPUMISAN BABY | 121 542 | 20.0% | 35.2% | 2 | 94 117 783 | 27.3% | 49.9% | 3.3 | 13.2% |
| FASTUM | 74 252 | 7.7% | 0.8% | 0 | 44 694 797 | 8.0% | 2.1% | -0.1 | 11.6% |
| IODOMARIN | 354 624 | 19.8% | 25.0% | 1.8 | 63 733 938 | 20.2% | 9.9% | 0.9 | 11.4% |
| LIOTON | 79 829 | -10.6% | 1.9% | -0.4 | 95 544 768 | -8.1% | 3.8% | -0.7 | 8.7% |
| MEZYM | 1 044 774 | 13.9% | 17.4% | 0.4 | 180 805 122 | 15.6% | 12.7% | 0.4 | 11.5% |
| MIG | 632 616 | -2.0% | 2.5% | -0.2 | 83 796 209 | 1.7% | 1.9% | -0.1 | 5.2% |
| PROSTAMOL | 113 178 | 16.3% | 13.6% | -0.5 | 187 439 877 | 17.6% | 16.3% | -0.4 | 20.9% |
| RESPERO MYRTOL | 146 557 | 22.5% | 8.3% | 0.4 | 76 853 359 | 21.4% | 8.6% | 0.1 | 16.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs